|
|
|||||||||
|
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. Type 508 Accommodation and the title of the report in the subject line of e-mail. Current Trends Antigenic Analysis of Recent Influenza IsolatesInfluenza type A(H1N1) and type B viruses received at CDC thus far this winter from outbreaks and sporadic cases in the United States have been closely related to the reference strains A/England/333/80(H1N1) and B Singapore/222/79, respectively. Since about July 1981, influenza type A(H3N2) viruses have been received from Australia, Chile, Guam, Indonesia, Japan, People's Republic of China, Taiwan Province of China, and Trinidad and Tobago. As in the preceding year, the isolates have exhibited heterogeneous reaction patterns in hemagglutination-inhibition tests with ferret serum specimens. Varying proportions of the viruses from different locations are more closely related to A/Texas/1/77 or A/Bangkok/1/79. A minority of recent isolates have been found to exhibit some further antigenic drift from earlier strains and to resemble the virus A/Shanghai/31/80 isolated in December 1980 from a sporadic case of influenza. As shown in Table 1, A/Shanghai/31/80 exhibits an asymmetric antigenic difference from A/Bangkok/1/79, in that antiserum to A/Bangkok/1/79 usually inhibits the variant to a titer 4-fold lower than homologous, whereas antiserum to A/Shanghai/31/80 reacts almost equivalently with itself and with A/Bangkok/1/79. A further characteristic of A/Shanghai/31/80-like viruses is their low inhibition by A/Texas/1/77 and A/Bangkok/2/79 antisera. The above-described variants have been isolated concurrently, and there is no clear evidence of A/Shanghai/31/80-like viruses, for example, achieving predominance and being responsible for major outbreaks or epidemics in Asia or elsewhere. Prevalence of antibody to A/Bangkok/1/79 and A/Shanghai/31/80 appears similar in the general population in the United States and the United Kingdom, where this has been studied by the WHO Collaborating Centers for Influenza. Disclaimer All MMWR HTML documents published before January 1993 are electronic conversions from ASCII text into HTML. This conversion may have resulted in character translation or format errors in the HTML version. Users should not rely on this HTML document, but are referred to the original MMWR paper copy for the official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices. **Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.Page converted: 08/05/98 |
|||||||||
This page last reviewed 5/2/01
|